Toggle Main Menu Toggle Search

Open Access padlockePrints

Time-independent disease state identification defines distinct trajectories determined by localised vs systemic inflammation in patients with early rheumatoid arthritis

Lookup NU author(s): Professor Rachel Knevel

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2025 The Author(s)Objectives: Patients with rheumatoid arthritis (RA) display different trajectories towards improvement of disease. We aimed to disentangle the heterogeneity of RA disease trajectories from the first clinical visit onwards using graph-based pseudotime analysis. Methods: We studied early patients with RA over 1.5 years in 2 data sets: Leiden (Netherlands), n = 1237, with 5017 visits, and Towards a Cure for Early Rheumatoid Arthritis (TACERA) (United Kingdom), n = 243, with 750 visits. We created a pipeline for time-independent clustering of clinical and haematologic features to identify disease states. Sequence analyses of these states defined the trajectories. We studied the predictability of the trajectories with baseline features. Results: Clustering identified 8 disease states with localised inflammation (joints) and systemic inflammation (erythrocyte sedimentation rate [ESR] or leucocytes) as the main discriminating factors. The disease state sequences consisted of 4 trajectories, which we independently replicated in TACERA: A, high ESR; B, rapid progression from many inflamed joints towards remission; C, high leucocytes; and D, many inflamed joints with poor prognosis. Systemic vs local inflammation patterns showed moderate predictability at baseline (sensitivity of 71% and precision of 0.73 for trajectory A, although lower precision of 0.52 for trajectory B), while other trajectories were less predictable. Trajectories C and D had strong resemblance with B at baseline but deteriorated into less favourable trajectories. Patients in trajectory A were more often female and on average older. The trajectories were not explained by time till disease-modifying antirheumatic drug, baseline disease activity, or symptom duration. The suboptimal trajectories coincided with worse patient-reported outcomes, even when the inflammation was mainly systemic. Conclusions: We identified 4 distinct trajectories in early RA, differentiating RA into localised vs systemic inflammation. Our results highlight potential differences in disease pathology and opportunities for further targeted treatment. Inevitably, patterns without linkage to our selected features could not be detected.


Publication metadata

Author(s): Steinz N, Maarseveen TD, van den Akker EB, Cope AP, Isaacs JD, Winkler AR, Huizinga TWJ, Abraham Y, Knevel R

Publication type: Article

Publication status: Published

Journal: Annals of the Rheumatic Diseases

Year: 2025

Issue: ePub ahead of Print

Online publication date: 09/05/2025

Acceptance date: 08/04/2025

Date deposited: 21/05/2025

ISSN (print): 0003-4967

ISSN (electronic): 1468-2060

Publisher: Elsevier B.V.

URL: https://doi.org/10.1016/j.ard.2025.04.011

DOI: 10.1016/j.ard.2025.04.011

Data Access Statement: We have made our scripts available in a public repository at: https://github.com/nilssteinz/Early_RA_Trajectories. Study data are available upon reasonable request.


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Horizon Europe programme [101095052] (SQUEEZE), [101080711] (SPIDERR), and [777357] (RTCure)
owards a Cure for Early Rheumatoid Arthritis (TACERA
RC/ABPI Inflammation and Immu- nology Initiative Grant [MRC reference numbers: G1001516 and G1001518]
ZonMw Open Competitie 2021 [09120012110075]
ZonMw klinische fellow [40-00703-97-19069]

Share